Pseudogenes are duplicated yet defunct copies of functional parent genes. However, some pseudogenes have gained or retained function. In this study, we consider a functional role for the NLRP2-related, higher primate-specific, processed pseudogene NLRP2P, which is closely related to Pyrin-only protein 2 (POP2/PYDC2), a regulator of nuclear factor-kB (NF-kB) and the inflammasome. The NLRP2P open-reading frame on chromosome X has features consistent with a processed pseudogene (retrotransposon), yet encodes a 45-amino-acid, Pyrin-domain-related protein. The open-reading frame of NLRP2P shares 80% identity with POP2 and is under purifying selection across Old World primates. Although widely expressed, NLRP2P messenger RNA is upregulated by lipopolysaccharide in human monocytic cells. Functionally, NLRP2P impairs NF-kB p65 transactivation by reducing activating phosphorylation of RelA/p65. Reminiscent of POP2, NLRP2P reduces production of the NF-kB-dependent cytokines tumor necrosis factor alpha and interleukin (IL)-6 following toll-like receptor stimulation. In contrast to POP2, NLRP2P fails to inhibit the ASCdependent NLRP3 inflammasome. In addition, beyond regulating cytokine production, NLRP2P has a potential role in cell cycle regulation and cell death. Collectively, our findings suggest that NLRP2P is a resurrected processed pseudogene that regulates NF-kB RelA/p65 activity and thus represents the newest member of the POP family, POP4.
INTRODUCTION
The innate immune system senses numerous danger and pathogen-associated molecular patterns via germline-encoded pattern-recognition receptors. These receptors include toll-like receptors (TLRs), RIG-I helicase-like receptor and NOD-like receptors (NLRs) (as reviewed in Martinon et al. 1 ). Engagement of pattern-recognition receptors leads to cooperative signaling between MAPK and nuclear factor-kB (NF-kB) pathways to drive transcription of pro-inflammatory cytokines, assembly of NLR inflammasomes and cell death. 2 The NF-kB family of transcription factors regulate expression of various cytokine genes involved in the immune response and inflammation, for example, tumor necrosis factor alpha (TNFa), interleukin (IL)-6 and IL-1b (as reviewed in Ghosh and Hayden 3 ). The NF-kB proteins RelA/p65, RelB, c-Rel, p50 and p52 form homoor heterodimers that control gene transcription. 4 NF-kB is generally sequestered in the cytoplasm by inhibitor of NF-kB (IkB) proteins. Upon stimulation, phosphorylation of IKB by IKK leads to IKB degradation, thus freeing the NF-kB dimer (p50/ RelAp65, in the case of the canonical pathway), which translocates to the nucleus and drives transcription of target genes. 3, 4 Aberrant regulation of NF-kb results in a multitude of pathological conditions including multiple sclerosis, atherosclerosis, cancer, arthritis, type I and type II diabetes and Alzheimer's disease. 5 Proper regulation of NF-kB is therefore highly desirable.
Mammalian genomes encode multiple NLR proteins, 6 patternrecognition receptors, which contain a central nucleotide-binding domain, C-terminal leucine-rich repeats and differing N-terminal 'effector' domains, typically a caspase recruitment domain or pyrin domain (PYD). 7 Caspase recruitment and PYD domains drive homodomain interactions facilitating the formation of an 'inflammasome' complex by certain NLRs, thus recruiting and activating caspase-1 to cleave pro-IL-1b and proIL-18 to their active forms. 8, 9 Several human inflammatory and febrile diseases have been attributed to mutations within NLRP3 10, 11 and reviewed in Mitroulis et al., 12 leading to the periodic or chronic overabundant IL-1b production responsible for the pathology. Moreover, given the role of IL-1b in innate inflammatory responses, polarization of Th17 cells [13] [14] [15] and T-cell-dependent antibody production, 16, 17 tight regulation of these inflammasomedependent responses is important.
Interestingly, proteins capable of regulating NF-kB activation and inflammasome activation have recently emerged in higher primates, 18, 19 including the Pyrin-only proteins (POPs), which are composed strictly of a PYD. 18, 20, 21 Human POP1 and POP2 disrupt NF-kB at the level of IKK kinase activity and RelA/p65-mediated transactivation, respectively. 18, 21, 22 Further, POP2 disrupts the PYD-PYD interaction required for assembly and activity of some inflammasomes, including NLRP3. 22 However, POP3 regulates neither NF-kB nor NLRP3 inflammasomes, but instead inhibits formation of AIM2-like receptor inflammasomes. 20 In mammals, POP genes are limited to hominids and Old World primates, suggesting an evolutionary pressure to control inflammatory response at both the level of cytokine gene transcription and processing of IL-1b. 19, 22 However, some viruses also encode POPs (vPOPs). Specifically, Myxoma protein (M013L) and Shope fibroma virus protein (SVF-gp013L), which are similar in sequence to POP1, inhibit PYD-dependent inflammasomes, [23] [24] [25] and impair NF-kB nuclear translocation. 26 In the case of myxoma virus, the M013L vPOP is required for virulence.
non-processed. Processed pseudogenes result from the retrotransposition of messenger RNA (mRNA) to a distal site in the genome without associated promoter or intron sequences. 27 Nonprocessed pseudogenes arise from gene duplication and typically include both the proximal promoter elements and introns. 28 In both cases, premature stop codons, alternate splice sites and other alterations generally prevent transcription and translation. 29 However, pseudogenes are not always indicative of non-functional sequences. The generation of pseudogenes may have been important for the development of variable region genes contributing to the diversity of immunoglobulins. 30 Further, transcribed processed pseudogenes, that is, pseudogene mRNA, may have a role in regulating expression of their parent genes as is the case of pseudo-NOS 31 and PTENP1. 32, 33 Two NLR pseudogenes, CLR12.1 and CLRX.1/NOD24 (NLRP2P), were previously identified in the human genome. 7 Of these, NLRP2P is interesting as both the POP2 and NLRP2P loci arose through retrotransposition of an NLRP2/7-like gene. 19 Notably, a syntenic NLRP2P locus is present in the genomes of humans, chimpanzees, orangutans and Rhesus macaques. 7, 19 These loci each contain remnants of the NLRP2/7-like nucleotide-binding domain and leucine-rich repeat-coding domains as well as an ATG-initiated conserved open-reading frame (ORF) comprising a short, but substantial, portion of the PYD. Therefore, we considered whether NLRP2P might represent a functional gene similar to POP2. Our data reveal that NLRP2 is expressed and inhibits NF-kB signaling upstream of pro-inflammatory cytokine release, albeit in a fashion somewhat different from POP2, suggesting that NLRP2P likely represents a resurrected pseudogene and a new member of the POP family.
RESULTS

NLRP2P mRNA is expressed in human tissues
Retrotransposition of an NLRP2/7-like mRNA yielded a processed pseudogene that gave rise to a functional POP2 gene in Old World primates, apes and humans. 18, 19, 22 Although NLRP2P was initially described as a pseudogene, the ORF codes for a predicted protein of 45 amino acids that shares with POP2 residues important for NF-kB inhibition. This warranted closer examination of the NLRP2P locus.
Pseudogenes result from either gene duplication followed by loss of expression and/or function (non-processed) owing to random mutation events or by retrotransposition of an mRNAderived sequence into a site distant from the parent locus that lacks the sequences needed for expression (processed). Table 1 compares the features of the NLRP2P locus with those of processed and non-processed pseudogenes. NLRP2P is located on chromosome X (distant from NLRP2 and NLRP7 on chromosome 19) , contains a discernable poly-(A) tract near the remnants of the 3 0 end of the NLRP2/7-related sequence, lacks NLRP2/7 introns and has multiple stop codons. Therefore, NLRP2P most closely resembles a processed pseudogene. However, unlike true processed pseudogenes, NLRP2P retains an ORF largely corresponding to the first 45 codons of NLRP2. The human NLRP2P ORF sequence is 95, 91 and 92% homologous to Pan troglodytes (chimpanzee), Pongo abelii (orangutan) and Macacca mulata (rhesus macaque), respectively (Pongo abelii, has a stop codon after the first 19 codons, a mutation that likely occurred after the divergence of orangutans and chimps), suggesting sequence conservation expected to be absent in a pseudogene. Further, the NLRP2P record in the NCBI database (NG_002752.4) predicts a short 68-bp intron downstream of the ORF that is absent in both NLRP2 and NLRP7, a feature unexpected in DNA thought to be non-coding. Finally, multiple putative transcription factor-binding sites are present upstream of the ATG, suggesting a potential promoter region. These characteristics and the similarity of the translated NLRP2P ORF to POP2 raised the possibility that NLRP2P might represent an expressed and potentially functional pseudogene.
To determine whether NLRP2P mRNA is transcribed, primers were designed to amplify a sequence downstream of the predicted stop codon, thus preventing detection of the highly similar POP2 and NLRP2 sequence ( Figure 1a) . Further, based on the sequence, NLRP2P primers were designed to span the predicted 68-bp intron, which was within the only unique sequence of the gene. Using these primers to screen a human complementary DNA (cDNA) tissue panel, we found that NLRP2P is expressed, at some level, in all tissues tested (Figure 1b) . Weak expression was also detected in human endothelial cells (HUVEC), the macrophage cell line THP-1 and in primary human leukocytes.
Upon exposure to inflammatory stimuli (for example, infection and lipopolysaccharide (LPS) treatment), cells upregulate expression of various genes involved in mediating and regulating inflammation, including POP2. 22 Treatment of THP-1 cells with LPS increased expression of NLRP2P message (Figure 1b) , suggesting that NLRP2P may be induced during inflammation or infection. Interestingly, in poly(A)-purified cDNA tissue samples, the larger 220-bp amplicon corresponding to the non-spliced sequence was present in all samples, whereas the 153-bp amplicon, lacking the 68-bp intron, when detected, was weakly amplified and observed solely in the placenta, peripheral blood leukocytes and bone marrow (Figure 1b) . Despite detection in all tissue types tested, NLRP2P was not detectable in epithelial (HeLa) or fibroblast-like (A293T) cells, suggesting that specialized cells within the respective tissue samples express NLRP2P and not the associated epithelium. Collectively, while NLRP2P has many characteristics similar of a processed pseudogene, these data demonstrate that NLRP2P produces an mRNA transcript in multiple human tissues, is induced by inflammatory stimuli and may utilize a seemingly de novo intron in a tissue-restricted fashion. These processes are all inconsistent with the designation of NLRP2P as a pseudogene.
A physiological role is predicted for genes where nonsynonymous mutations are selected against. 34 We recently demonstrated that POP2 is under strong selective pressure and that the first 19 amino acids of POP2 are necessary and sufficient for its function. 19 Therefore, we examined synonymous versus non-synonymous substitutions in NLRP2P between the human, chimp and orangutan reference sequences as an indicator of evolutionary-selective pressure (Figure 2 ). The entire NLRP2P-coding region appears to be under purifying selection regardless of which two species were compared (Figures 2a-c) . Codon-bycodon analysis using 2554 nt of sequence from each species also reveals purifying selection in the coding region with the exception of residues at positions 5, 21, 24, 27, 31 and 38 ( Figure 2d ). In the predicted human NLRP2P protein, all of these residues (except position 24) match POP2, suggesting a potential selective pressure toward the POP2 sequence. Surprisingly, the in-frame sequence beyond the first stop codon in human and chimp NLRP2P ORF (codons 47-230) also appears to be under selection. Beyond codon 230 (codons 231-848), there is no evidence of selective pressure. Thus, like POP2, the retained coding sequence within NLRP2P is likely under recent and strong selective pressure, suggesting further that NLRP2P is a functional gene. Collectively, these observations suggest that NLRP2P should no longer be considered a pseudogene, but rather a bona fide cellular gene, which we now term POP4.
POP4 blocks NF-kB signaling at or downstream of RelA/p65 Given the above, POP4 is expected to be functionally comparable to POP2. The ORF of POP4 was therefore cloned into a FLAGencoding expression vector. Since POP4 (45 amino acids (a.a.)) is shorter than POP2 (97 a.a.) and other PYDs, POP4 likely forms only the first two a-helices. The first a-helix of POP2 is necessary and sufficient to inhibit transcription initiated by the transactivation domain 1 (TAD1) of NF-kB RelA/p65 (residues 519-540). 22 Further, the first a-helix of POP4 is essentially identical to POP2 (Figure 3a ), differing only in residues shown to be dispensable for NF-kB inhibition. 22 Therefore, we anticipated that POP4 should inhibit NF-kB activation at or downstream of RelA/p65. Similar to POP1 and POP2, POP4 significantly reduced NF-kB promoter/reporter activity in response to TNFa (Figure 3b ). Expression of POP1 and POP2 in this system was confirmed by immunoblot (Figure 3b , inset). Although the predicted molecular mass of POP4, B5 kDa, likely accounts for our lack of detection by western blot, intracellular POP4 was detectable (Figure 3b, right panel) . Further, POP4, as well as POP2, reduced activation mediated by exogenously expressed RelA/p65 (Figure 3c , left panel), but had no effect on transcription driven by the NF-kB-independent SV40 promoter ( Figure 3c , right panel). As previously noted, POP1 does not impact the activity of RelA/p65. Together, these data suggest that, like POP2, POP4 acts at or downstream of RelA/p65 to block NF-kB activity.
POP4 does not disrupt NLRP3 or ASC-mediated IL-1b release PYD-ASC interactions are required for assembly of various inflammasomes critical to IL-1b release, including NLRP3 and AIM2. 8, 35, 36 POP2 disrupts ASC-PYD interactions 18 and blockade of inflammasome assembly by POP2 has been linked to a-helices 1 and 4; however, the first a-helix alone is necessary and sufficient to reduce inflammasome activity.
22 POP4 completely lacks PYD helices 4 through 6. In addition, POP4 lacks the acidic residues at positions 6 and 16 present in the first a-helix of POP2. Mutation of these residues in POP2 (E6Q and/or E16G) disrupts inhibition of the NLRP3 inflammasome. 22 Given the lack of helix 4 and non- acidic residues at positions 6 and 16 in POP4, we predicted that POP4 neither inhibits these inflammasomes nor impairs the release of mature IL-1b. Indeed, POP4 failed to prevent release of IL-1b from cells expressing a reconstituted NLRP3 inflammasome ( Figure 3d ). Overexpression of ASC without an NLR in such reconstitutions also elaborates IL-1b, likely through either an endogenous unknown inflammasome scaffold protein or concentration-dependent oligomerization of ASC. 22, 36, 37 Regardless of mechanism, POP2 inhibits this inflammasome as well. 22 Even with increasing concentrations, POP4 was unable to block ASCdependent IL-1b release (Figure 3e ). Therefore, POP4 appears not to be an inhibitor of the NLRP3 inflammasome and is unlikely to inhibit other ASC-dependent inflammasomes, suggesting a more exclusive role impacting the NF-kB signaling pathway.
POP4 localizes to the nucleus upon TNFa stimulation, but does not alter RelA/p65 localization In transfected HeLa cells, POP2 localizes primarily to the cytoplasm, but some cells demonstrate nuclear localization. Thus, we determined the cellular distribution of FLAG-tagged POP4 in HeLa cells. Although cytoplasmic localization was more predominant, some cells with nuclear concentration of POP4 were observed (Figure 4a ). POP2 may block p65 in part through reducing its nuclear presence, 18 and POP4 might function similarly. Therefore, we also examined the localization of POP4 and RelA/p65 following TNFa stimulation. Without treatment, localization of both POP4 and p65 was diffuse (Figure 4b ). However, by 30 min of TNFa stimulation, POP4 was predominately nuclear as was p65. Indeed, there was no significant difference in the number of cells displaying nuclear p65 following TNFa treatment in the presence or absence of POP4 (Figure 4c ), demonstrating that, surprisingly, unlike POP2, POP4 does not prevent or alter p65 nuclear localization. Further, TNFa treatment also induces the nuclear translocation of POP4 in the majority (80%) of transfected cells (Figure 4d ). The concomitant nuclear import of POP4 and p65 is consistent with our Gal4-p65 data (see below) and suggests that POP4 may limit p65 transcriptional activity in the nucleus.
POP4 impairs p65 transactivation potential by reducing phosphorylation of S536 As POP4 blocks NF-kB p65 activity and POP2 is known to block p65 transactivation potential, 22 the ability of POP4 to disrupt p65 transactivation potential was determined. Cells were transfected with a construct producing the DNA-binding domain of Gal4 fused to the 30 amino-acid, C-terminal TAD1 of p65 (residues 519-550), which drives transcription from a 5XGAL4-luciferase reporter construct (Figure 5a ), and POP4 disruption of this activity was assessed. Similar to POP2, POP4 blocked transactivation by GAL4-p65 (TAD1), indicating that transactivation by the isolated TAD1 domain is inhibited (Figure 5b ). To further address the mechanism of NF-kB inhibition and explore the role of POP4 in macrophages, stable transfectants of POP4 were generated in the mouse J774A.1 cell line and three clones were isolated with various levels of POP4 expression (Figure 5c, left panel) . A polyclonal population of POP4-expressing J774A.1 cells was also produced by pooling POP4-expressing clones (Figure 5c, right panel) .
Phosphorylation of serine 536 (S536) within the TAD1 of p65 is essential for maximal transactivation in response to TNFa and LPS. 4 To determine whether POP4 impairs p65 transactivation by reducing S536 phosphorylation, p65-S536 phosphorylation status was monitored over time in nuclear and cytoplasmic fractions of the POP4-G7 cells post TNFa treatment. At 5 min post TNFa, phospho-S536 p65 (pp65) is detected in the nuclear fraction of the control transfectant (Figure 5d ). In contrast, the appearance of pp65 is largely attenuated in the POP4-G7 clone. The relative quantity of nuclear pp65 relative to total p65 was also determined for each time point (Figure 5e ). On the basis of this quantitation, after 5 min of TNFa treatment, nuclear pp65 accounts for B90% of total p65, whereas by 30 min, nuclear pp65 in the POP4-G7 clone reaches only 40%. This suggests that POP4 is preventing the phosphorylation of RelA/p65 in J774A.1 cells. Nuclear accumulation of pp65 was measured for three independent clones (G7, D5 and B9) with graded POP4 expression (Figure 5f ). At the 5-min time point, nuclear pp65 was reduced in the B9, D5 and G7 clones to 30, 49 and 74%, respectively. The extent to which nuclear pp65 accumulation is diminished in these clones corresponds to their level of POP4 expression. Since nuclear accumulation of NF-kB is reflective of S536 phosphorylation status, we assessed the frequency of J774A.1 cells exhibiting nuclear p65 in POP4 clones D5 and G7 to further confirm that POP4 is reducing phosphorylation of p65 ( Figure 5g ). As anticipated, both G5 and D7 POP4 clones exhibited fewer cells with nuclear p65 at 10 and 30 min post LPS treatment. Together, these results strongly suggest that POP4 limits NF-kB phosphorylation of S536 in these cells, thereby reducing transactivation by the p65 TAD1. Curiously, although p65 translocation to the nucleus was largely unimpaired in HeLa cells, in J774-POP4 cells, nuclear fractions appear to contain less p65; however, nuclear translocation still occurs to a measurable degree. Nevertheless, POP4 reduces the amount of S536-phosphorylated p65 suggesting an impact of POP4 on a kinase or phosphatase targeting S536 and reducing the transactivation potential of RelA/ p65. Given the inhibition of Gal4-p65 (TAD1), this is likely to occur in the nucleus.
The ability of RelA/p65 to protect cells from apoptotic death is well studied using both RelA/p65-deficient mice, primary cells and various transformed cell lines. 38, 39 Accordingly, the response to TNFa, (via RelA/p65) is important for development, immune homeostasis and immune control of tumors. 40 As POP4 inhibits RelA/p65, it may also influence cell survival. Inhibition of protein synthesis with cycloheximide (CHX) sensitizes HeLa cells to TNFa-induced cytotoxicity. 41 POP4 expression in transfected HeLa cells did not significantly alter cellular proliferation with CHX and TNFa treatment, however, in the presence of CHX alone, POP4 led to a reduction in cellular proliferation (Figure 6a ). Cell cycle analysis revealed that in CHX-treated cells POP4 disrupts progression through the S/G2 phase (Figures 6b and c) . Further, apoptosis (as indicated by hypodiploid nuclei) was significantly increased by POP4, but only in the presence of both CHX and TNFa (Figure 6d) . Surprisingly, under the same conditions, POP2, which also blocks p65 transactivation, 22 had no appreciable impact (Figure 6d ). These data suggest that under appropriate conditions POP4 might restrict cell cycle progression and promote apoptotic cell death, features consistent with its ability to inhibit RelA/p65. POP4 reduces pro-inflammatory cytokine release elicited by TLR ligands or infection In macrophages, POP4 reduction in p65 transactivation is predicted to reduce NF-kB-dependent cytokine elaboration. We therefore monitored the impact of POP4 expression on production of the NF-kB-dependent cytokines TNFa and IL-6 following stimulation with the TLR1/2 agonist Pam3CysK4 and the TLR4 agonist LPS. TLR2 agonists are weak inducers of IL-6 in both cell lines and primary murine macrophages, whereas TLR4 agonists are strong inducers. 42 We obtained similar results following Pam3CysK4 and LPS stimulation of J774A.1 macrophages, where Pam3CysK4 induced picrogram quantities of IL-6 versus the nanogram quantities seen with LPS (Figures 7a and b) . However, in both individual and polyclonal populations of stable-transfected POP4-expressing J774A.1 cells, POP4 reduced IL-6 and TNFa release relative to vector-only controls in response to LPS (Figure 7a ) and Pam3CysK4 (Figure 7b ). In addition, TNFa was also reduced in POP4-expressing J774 cells compared with controls following infection with the mouse pathogen Francisella tularensis ssp. novicida (U112, Figure 7c) , 43 which is recognized by TLR2. 44 These gain-of-function studies demonstrate that production of the NF-kB-dependent cytokines TNFa and IL-6 following stimulation with different PAMPs is reduced by POP4 and suggest that in vivo, POP4 may act to regulate human macrophage production of NF-kB-dependent, pro-inflammatory cytokines. ). Cells were stained with anti-FLAG and Alexa488 secondary antibody to detect FLAG-POP4 together with anti-p65 and Alexa594 secondary antibody plus DAPI. The percentage of POP4-expressing cells with nuclear p65 (c) or nuclear POP4 (d) in the absence or presence of TNFa was determined from multiple images represented in (b). POP4-stable J774A.1 cells were produced by transfecting cells with FLAG-POP4. Expression was determined by flow cytometry for the intracellular FLAG tag from selected clones and a polyclonal population (d).
To confirm a likely physiological role for POP4 in human myeloid cells, we attempted an RNAi knockdown of POP4 in phorbol myristate acetate-differentiated THP-1 cells and examined the production of IL-6 and TNFa. A unique sequence in the 3 0 untranslated region (UTR) of POP4 (Figure 1a ) was targeted using small interfering RNA (siRNA). Not surprisingly, as RNA is a TLR3 agonist and TLR4 engagement leads to POP4 expression, the POP4 message was similarly induced following transfection with any RNA duplex, phorbol myristate acetate or LPS (Figure 7d) . Therefore, we utilized varying concentrations of POP4 siRNA to determine at what dose POP4 knockdown could be achieved. In contrast to THP-1 cells treated with LPS alone, knockdown of POP4 expression was observed in LPS-treated THP-1 receiving 250 ng of POP4 siRNA (B1.0 pg per cell) (Figure 7d ). Introduction of greater quantities of POP4 siRNA were less effective, likely owing to the competing ability of the RNA duplexes to induce additional POP4 expression. In cells with reduced POP4 expression (250 ng siRNA), there was a statistically significant increase in IL-6 and TNFa cytokine release as compared with control cells (Figure 7e ). Cells exhibiting induction of POP4 relative to controls produced slightly reduced levels of IL-6 and TNFa (data not shown). Thus the relative absence of POP4 is associated with increased TNFa and IL-6 production, demonstrating that the impact of POP4 on NF-kBdependent cytokine production in mouse macrophages can be extended to cells of human origin. These results are highly similar to those previously obtained with POP2, 22 consistent with the high degree of sequence similarity between these proteins.
DISCUSSION
Collectively, our findings support the re-classification of the higher primate-restricted NLRP2P pseudogene (CLRX.1/NOD24) as a functional gene, POP4. Initially thought to be inert, POP4 exhibits the capacity to negatively regulate NF-kB p65 activity through reduction of S536 phosphorylation within the TAD 1 of p65. This mechanism likely accounts for the reduced production of NF-kBdependent pro-inflammatory cytokines downstream of TLR signals when POP4 is expressed.
During the course of higher primate evolution, an NLRP2-like message gave rise to two apparent pseudogenes now evident within the human genome. One of these pseudogenes, POP2, was whittled down from the much larger NLRP2-like sequence into a ). Western blots for p65 and phosphorylated p65 (S536) and b-actin following cytoplasmic and nuclear fractionation (d). Bands were quantified by densitometric analysis and the relative percentage of nuclear, phosphorylated p65 (S536) versus total cellular p65 was calculated for the indicated clones and time points (e and f ). J774A.1 POP4 and vector-only clones were stimulated with LPS (200 ng ml À 1 ) and nuclear localization of p65 was assessed by measuring spectral similarity between cellular images obtained during flow cytometry (ImageStream). Relative frequencies of cells (out of 49000) with nuclear p65 are shown (g, left panel). Representative images of cells from the analysis exhibiting staining for DRAQ5 (nucleus, red), p65 (green) and co-localized nuclear p65/DRAQ5 (yellow) (g, right panel). For c-g, data are representative of at least two independent experiments. single exon gene, gained a promoter, developed a 3 0 UTR and had recently been appreciated for both its ability to reduce NF-kB signaling and disrupt the NLRP3 inflammasome, 18, 19, 22 features consistent with a newly emergent gene. Until this study, nothing was known about the other pseudogene, NLRP2P/POP4 beyond its presence in the genome. Although a non-coding POP2-processed pseudogene is present in the marmoset genome, no sequence data is available at present for the syntenic portion of marmoset chromosome X corresponding to NLRP2P. No sequences orthologous to POP4 were detected in the available New World primate genomes. Thus, it is presently unknown whether the insertion event leading to the NLRP2P locus occurred before, or after, the divergence of Old and New World primate species. Further, in all species examined, POP4 retains the non-coding remnants of the still discernable NLRP2-like sequences. Given the expression of POP4, its function and the apparent lack of more refined 5 0 and 3 0
UTRs, POP4 appears to be a gene in the midst of emerging from a processed pseudogene to a functional gene. The appearance of both POP2 and POP4 in higher primates demonstrates recent and strong selective pressure acting within these species. Although the nature of this selective pressure is unknown, a deleterious impact on the signaling pathways associated with innate immunity and inflammation, which POPs counteract, is likely. Over time, POP4 gained a unique insertion, a 68-bp intron within its 3 0 UTR, which is occasionally spliced in mRNA from peripheral blood leukocytes, bone marrow and most markedly in the placenta. Although this insertion could simply be the whittling away of non-coding NLRP2 remnants, these splice variants could serve a function. For example, the presence or absence of the intron may alter message expression, as observed for the tissuespecific element in the first intron of mycn. 45 Such a process could effectively restrict POP4 protein expression to those cells with the appropriate splice variant. Another possibility is that POP4 message may regulate itself or another related transcript (that is, POP2 or NLRP2). Such gene-targeted regulation has been described for some transcribed processed pseudogenes including control of neural nitric oxide synthase by its pseudogene, pseudo-NOS 31 and PTEN by its pseudogene, PTENP1. 32, 33 However, the observation that a cDNA version of POP4 exhibits the same function reflected by siRNA knockdown and that this function is consistent with our mutational studies of the POP2 protein support that POP4 is most likely acting as a protein.
Unlike POP2, neither POP4 nor POP1 block IL-1b release from the NLRP3 inflammasome in reconstitution assays. Although POP1 differs sufficiently from POP2 and POP4 to account for the observed lack of inflammasome inhibition, POP4 maintains a first a-helix almost identical to that of POP2. The inability of POP4 to block inflammasomes initiated by NLRP3 or ASC overexpression together with the absence of negatively charged residues at positions 6 and 16 that are critical for inhibition of these inflammasomes by POP2, 22 further establishes the importance of these residues for this function of POP2. Still, that POP4 might interfere with other inflammasomes remains possible.
Our work also highlights the dynamics of NF-kB activity and complexity in its cellular localization. As the physiological baseline levels, activation pathways, post-translational modifications, repressors and outcomes differ between cell type and stimulus, NF-kB signaling is considered so complicated that the use of an 'NF-kB pathway interactome' model has been proposed in place of the canonical pathway-centric model to study NF-kB. 46 POP4 effectively inhibits NF-kB at the level of p65, apparently through reducing S536 phosphorylation. How this is accomplished is unclear. Although we have not detected any physical interaction between p65 and POP2 or POP4, several kinases target S536, including IKKa. POP1 is reported to inhibit cytosolic IKKa and b upstream of IkBa phosphorylation, thus preventing nuclear translocation of p50-p65 heterodimers in epithelial cells. 21 However, as POP4 does not inhibit the localization of p65 in HeLa cells, it is more likely that POP4 prevents the action of another S536 kinase. A more extensive time course of p65-S536 phosphorylation and consideration of whether the targeted phosphorylation event occurs before or after nuclear localization may be revealing and may help account for differences in p65 nuclear localization observed between mouse and human cell lines when POP4 is present. Alternatively, we cannot rule out the possibility that POP4 activates a phosphatase active toward NF-kB p65. Whether POP4 might also inhibit TAD2 activity or DNA binding by NF-kB is not yet known.
Like POP2, POP4 is induced by inflammatory stimuli consistent with its likely role as a regulator of inflammatory cytokine production. Curiously, exposure of THP-1 cells to siRNA duplexes leads to POP4 expression, suggesting that engagement of RNA- sensing receptors (for example, TLR3 or RLRs) may drive POP4 expression in an IRF3-dependent fashion. Whether TLR3 or IRF3 are necessary for POP4 induction will be the subject of further investigation. The impact of POP4 siRNA knockdown in THP-1 cells and heterologous expression of POP4 in J774A.1 cells on the production of LPS-induced TNFa is comparable to that seen with POP2 in similar experiments. 22 However, POP4 has a more profound effect upon Pam-3CysK-induced TNFa, than previously observed for POP2. Although these comparisons may reflect technical variations, it remains possible that POP4 acts more extensively than POP2 or has an additional capacity to influence TLR2 signals leading to TNFa. Collectively, the action of POP4 to temper inflammatory cytokine responses is very similar to that seen with POP2 and supports the hypothesis that POPs serve as a family of inflammatory regulators.
Beyond its impact upon the inflammatory response elicited by macrophages, POP4 appears to promote cell cycle arrest at S/G2/ M and contribute to apoptotic cell death in HeLa cells. Although likely a consequence of RelA/p65 inhibition by POP4, these studies do not rule out other potential explanations. In fact, the inability of POP2, which also inhibits NF-kB, to mediate similar effects suggests an unexpected function that may be distinct from NFkB inhibition or reflect unappreciated differences in the magnitude or mechanism of inhibition. It will be of interest to further consider the role of POP2 and POP4 in cell cycle control and survival. Nevertheless, the results of these experiments are important as a role beyond controlling inflammation is implicated. Specifically, as POP4 is broadly expressed and demonstrates enhancement of apoptotic activity in a transformed cell line, it may have a role in tumor suppression.
Again, this initial characterization of POP4 has the potential to reveal aspects of POP2 function. POP4 is approximately half the size of POP2 (owing to the stop codon that precludes translation of a-helices 4-6) and lacks key amino acids in a1 and a2 that are important for inflammasome inhibition by POP2. The first a-helix of POP2 in isolation is sufficient to disrupt p65 activity, 22 consistent with our POP4 data. However, localization of p65 is clearly not altered by POP4 in HeLa cells, unlike POP2 that appears to have multiple impacts on p65 localization including blockade of nuclear import, nuclear redistribution and generalized loss of p65. 18 Further, POP4 translocates to the nucleus upon TNFa stimulation, which is not observed for full-length POP2. 18 These observations suggest that the later helices of POP2, absent in POP4, might account for the different pattern of POP2 localization, the loss of nuclear p65 in POP2-expressing cells following TNFa stimulation and its inability to promote apoptosis and cell growth defects.
We have demonstrated that a previously classified pseudogene, NLRP2P, encodes a functional gene product (POP4) similar to POP2 in sequence and the capacity to regulate NF-kB-dependent proinflammatory responses. Considering its function and its sequence relation to POP2, should POP4 be considered a pyrin-only protein? As members of the death domain-fold superfamily, PYDs have five to six amphipathic a-helices. 47 The 45 a.a. of POP4 code for only two of these, yet this study and our work with POP2 demonstrate the functional importance of this region. Thus it seems reasonable to include variants of the PYD as members of the POP family. Finally, the very small size of POP4 raises the possibility that other small, but potentially overlooked genes remain to be discovered, a likelihood highlighted by the paucity of studies examining the roles of a similarly sized family of caspase recruitment domainonly proteins thought to prevent caspase-1 recruitment to the inflammasome. 48 Why do higher primates have multiple POPs? Are POPs redundant? Although POP1, POP2 and POP4 have seemingly overlapping functions, they operate at different points (and in potentially different locales) during NF-kB activation. Most recently, POP3, a regulator of the AIM2-like receptor inflammasome formed by AIM2, was described. 20 Whether POP3 regulates the NF-kB pathway in any fashion remains unknown at this time. POP1 acts upstream of NF-kB release at the level of IKK, but, like POP4, without inhibiting the inflammasome. POP2 inhibits the inflammasome, but also inhibits NF-kB downstream at p65 transactivation, like POP4. However, POP4 localization may be predominantly nuclear following stimulation, unlike the infrequently nuclear POP2. In addition, POP4 expression appears ubiquitous in human tissues in contrast to POP2, which displays constitutive expression restricted to testis and peripheral blood leukocytes. This suggests non-redundancy and the possibility of cooperative regulation of inflammatory signals where three POPs with different modalities may modulate inflammatory responses at multiple steps within the pathway; from stimuli to signaling, to gene transcription, cytokine processing and eventually homeostasis. Verification of this hypothesis would establish that primate species possessing POPs have developed a complex system for regulating the response pathways leading to inflammation, which is likely important for our understanding of acute and chronic inflammation in human health and disease.
MATERIALS AND METHODS
Cell lines
J774A.1, HEK-293, HEK-293T and THP-1, A293T and HeLa cell cultures and maintenance have been previously described. 18, 22 HUVECs (graciously provided by Dr Mohamed Treback, Albany Medical College) were maintained in EMG-2 media (Lonza, Walkersville, MD, USA).
RNA extraction and reverse transcriptase-PCR
Cytoplasmic RNA from cell lines was extracted using the RNeasy Kit (Qiagen, Valencia, CA, USA) and treated with DNAse (Qiagen) to eliminate chromosomal DNA contamination. DNA-free RNA (500 ng) was reverse transcribed and amplified using the OneStep RT-PCR Kit (Qiagen) as directed by the manufacturer with the primers described below.
POP4 expression studies cDNA (5 ng) from the Human MTC Panel I and Human Immune System MTC Panel (Clontech, Mountainview, CA, USA) was used to detect POP4 expression in human tissues. Primers (forward: 5 0 -GCGTTTCGAAGCAGAAGC ACTAGA-3 0 , reverse: 5 0 -GCTGAACGGGATCAGCATCTTGTA-3 0 ) were designed to specifically amplify within the NLRP2P 3 0 UTR (Genbank Accession No.BK001116.1), a region that lacks homology with POP2 and NLRP2. Glyceraldehyde 3-phosphate dehydrogenase primers have been described previously. 49 For expression in human non-hemapoietic cell lines, RNA was extracted from B1 Â 10 6 untreated cells. THP-1 cells were cultured with or without LPS (100 ng ml 
Sequence analysis
One-dimensional sliding-window analysis of Ka and Ks (SWAKK) analysis was performed using the SWAKK algorithm with a window of 30. 50 Codon comparisons were performed using the Muse-Gaut model 51 of codon substitution and Tamura-Nei model 52 of nucleotide substitution to produce a joint maximum likelihood reconstruction of ancestral states and a tree. The test statistic dN-dS is used for detecting codons that have undergone positive selection, where dS is the number of synonymous substitutions per site (s/S) and dN is the number of non-synonymous substitutions per site (n/N). A positive value for the test statistic indicates an overabundance of non-synonymous substitutions. In this case, the probability of rejecting the null hypothesis of neutral evolution (P-value) is calculated and values of Po0.05 are considered significant. 53, 54 Normalized dN-dS for the test statistic is obtained using the total number of substitutions in the tree (measured in expected substitutions per site). Maximum likelihood computations of dN and dS were conducted using HyPhy software package. 55 The analysis included nucleotide sequences for the NLRP2P locus from human, chimpanzee and orangutan. All positions containing gaps and missing data were eliminated. There were a total of 848 positions in the final data set. Evolutionary analyses were conducted using the MEGA5 software package. 
POP4 cloning
The coding sequence from the ATG start site to the first stop codon of POP4 was synthesized and cloned into the pIDTSMART-AMP vector by IDT Inc. (Coralville, IA, USA). Using added EcoRI and XhoI sites, POP4 was then cloned in-frame into pcDNA3-FLAG and pcDNA3-myc to produce FLAGand Myc-tagged forms, respectively. The cloned POP4 sequence was confirmed by sequencing.
Generation of J774A.1 stable transfectants Stable POP4 and control transfectants were produced as previously described. 22 Briefly, 5 Â 10 6 J774A.1 cells were electroporated with 10 mg of PvuI linearized FLAG-POP4 or vector-only DNA (570 V, 25 mF) followed by selection in G418 (1 mg ml À 1 ) and isolation of clonal populations.
Flow cytometry POP4 expression was confirmed in transiently transfected HEK-293T or stable J774 clones by immunolabeling the FLAG tag followed by flow cytometry. HEK-293T cells were fixed in 1% paraformaldehyde for 30 min, permeabilized with saponin (30 min) followed by blocking with 1% bovine serum albumin. J774 clones (10 6 cells) were incubated with 0.5 mg of rat anti-mouse CD16/CD32 (Mouse BD Fc Block, BD Biosciences, San Jose, CA, USA) for 15 min on ice to block Fc receptors and then permeabilized and fixed using Cytofix/Cytoperm Plus (BD Biosciences), according to manufacturer's instructions. Cells were stained with (1:500) anti-FLAG M2 (Sigma-Aldrich) for 45 min on ice followed by (1:2000) goat anti-mouse Alexafluor 647 (Abcam, Cambridge, MA, USA) (HEK-293T) or (1:500) goat anti-mouse Alexafluor 488 (Invitrogen, Camarillo, CA, USA) (J774) for 30 min. Mouse IgG1 (1:2000) was used as for isotype control staining. Fluorescence staining was assayed using a FACSCanto flow cytometer (BD Biosciences) and the resulting data were analyzed using FlowJo 7.2.2 software (Tree Star, Ashland, OR, USA). Clonal populations (clones G7, D5 and B9) were selected for experiments based on the range of FLAG expression levels. For cytokine induction experiments a polyclonal population (Poly) comprised of several POP4-expressing clones was used to rule out clonal effects.
Cell proliferation and nuclei analysis
For proliferation, HeLa cells were seeded at 5 Â 10 4 and transfected the next day with empty vector or POP4 constructs, and then either left untreated or treated with CHX (20 mg ml À 1 ), TNFa (5 ng ml À 1 ) or CHX and TNFa for 24 h. Cells were then counted via trypan blue and the cell growth was determined. For propidium iodide staining, HeLa cells were seeded at 1.5 Â 10 5 and the next afternoon transfected with empty vector, POP2 or POP4 constructs and pLaminB-GFP, 57 and 24 h later cells were either left untreated or treated with TNFa (5 ng ml À 1 ) and/or CHX (20 mg ml À 1
). Flow cytometry and propidium iodide analysis of GFP þ nuclei (suggestive of transfected cells) was done as previously described. 57 Nuclei and cell cycle values were determined using FlowJo 7.2.2 software.
NF-kB luciferase and inflammasome reconstitution assays NF-kB luciferase assays were performed as described previously. 18 Briefly, HEK-293 cells were transfected with 3xNF-kB luciferase reporter (100 ng) and 24 h later treated with TNFa (10-20 ng ml À 1 ) to induce endogenous NF-kB. Following another 24 h, cells were lysed and luciferase activity quantified. Alternatively, 293T cells were cotransfected with either an empty vector or a POP expression vector (1 mg) and p65 (100 ng), and 24 h post transfection cells were lysed and luciferase activity quantified. HEK-293T cells were used to reconstitute the inflammasome as described previously. 22 Cells were seeded at 5 Â 10 4 cells per well in 24-well plates. Following overnight culture, the cells were transfected with plasmids encoding pro-caspase-1 (50 ng), pro-IL-1b (200 ng), ASC (10 ng) and NLRP3 (100 ng) in the absence or presence of POPs (500 ng). For determination of the dose response to POP4, 293T cells were transfected with plasmids encoding pro-caspase-1 and pro-IL-1b as indicated above, ASC (400 ng) and POP4 (0-1000 ng). Approximately 20 h post transfection, culture supernatants were harvested, centrifuged briefly to remove cellular debris and used for the measurement of secreted IL-1b by enzyme-linked immunosorbent assay (Invitrogen).
Immunofluorescence and western blotting HeLa cells, transfected with 1 mg of FLAG-POP4 or vector, were left untreated or treated for 30 min with TNFa (20 ng ml À 1 ) and stained as previously described using anti-FLAG M2. 18 Images were obtained using a Zeiss Axio Observer.Z1 fluorescence microscope (Carl Zeiss Microscopy, LLC, Thornwood, NY, USA). To determine the fraction of POP4-expressing cells demonstrating nuclear localization of p65, POP4-positive cells (4100) were counted and the percentage with nuclear p65 staining was expressed as a percentage of all cells counted. For western blotting, 1 Â 10 5 J774 cells were seeded and the next day treated with mTNFa (20 ng ml À 1 ). Nuclear and cytoplasmic proteins were fractionated using NE-PER Nuclear and Cytoplasmic Extraction Reagents (Thermo Scientific, Rockford, IL, USA). Antibodies used were Rb pS536-p65 (1:1000), Rb anti-p65 (1:500) and Rb bactin (1:1000). All antibodies were from Cell Signaling Technology (Danvers, MA, USA). Secondary antibody goat anti-rabbit-HRP was from Santa Cruz Biotechnology (Santa Cruz, CA, USA) at 1:5000. SuperSignal West Dura Substrate (Thermo Scientific) was used and chemiluminescence was detected on film. Densitometric analysis was performed using ImageJ software (US National Institutes of Health, Bethesda, MD, USA).
Immunofluorescence detection of nuclear p65
J774A.1 clones stably expressing POP4 were seeded at 3 Â 10 6 in 60-mm dishes and allowed to adhere before treatment with 200 ng ml À 1 LPS (O26:B6; Sigma-Aldrich). Cells were fixed in 1% paraformaldehyde (30 min), permeabilized with saponin (30 min) and stained with (1:50) anti-p65-NFkB (Santa Cruz Biotechnology) for 20 min followed by (1:200) goat antirabbit Alexafluor 488 (Invitrogen). Cells were washed with phosphatebuffered saline containing 2% fetal bovine serum and 1 mM EDTA to prevent clumping and stored in 1% paraformaldehyde at 4 1C. Nuclei were stained with (1:5000) DRAQ5 (Cell Signaling Technology) for 5 min before analysis. Cells were analyzed on an ImageStream MKII Fluorescence Cytometer (Amnis, Seattle, WA, USA) and images acquired and processed using the Image Stream Data Exploration and Analysis software. Percent nuclear p65 was calculated using a similarity analysis with a score of 2 or higher indicating nuclear NF-kB distribution. 58 
Statistics
Unless otherwise indicated, data shown is the mean of at least three independent experiments and error bars indicate s.e.m. Student's t-test (two-sample, unequal variance) was used to calculate P-values.
